Phase I trial of DSP 0565 for use in patients with treatment-resistant epilepsy.
Latest Information Update: 21 Feb 2012
At a glance
- Drugs DSP 0565 (Primary)
- Indications Epilepsy
- Focus Adverse reactions
- 21 Feb 2012 New trial record
Latest Information Update: 21 Feb 2012